Clinical Signatures of Tolerance: PBC Prognostic Scores, Responder Dynamics & MG Applications
9:00 am - Wednesday 4th March 2026
- Explore in-depth clinical analyses of PBC including UK-PBC scoring, ALBI/GLOBE metrics, and emerging biomarkers to understand how tolerance influences disease prognosis
- Highlight responder outcomes, including responder-rate evaluation and respondercurve profiling following tolerance induction
- Delve into how these findings support translation into Myasthenia Gravis (MG), outlining clinical implications and future development strategy
